NYSEAMERICAN:INUV - Inuvo Stock Price, Forecast & News

Inuvo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INUV."

Inuvo Inc (NYSEAMERICAN:INUV) issued its quarterly earnings results on Wednesday, August, 14th. The technology company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.07. The technology company had revenue of $14.05 million for the quarter, compared to analysts' expectations of $13.30 million. View Inuvo's Earnings History.

Inuvo is scheduled to release their next quarterly earnings announcement on Friday, March 20th 2020. View Earnings Estimates for Inuvo.

Media coverage about INUV stock has been trending somewhat negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Inuvo earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Inuvo.

Inuvo saw a decrease in short interest in January. As of January 31st, there was short interest totalling 502,100 shares, a decrease of 14.1% from the January 15th total of 584,300 shares. Based on an average daily volume of 355,400 shares, the short-interest ratio is currently 1.4 days. Approximately 1.2% of the shares of the stock are sold short. View Inuvo's Current Options Chain.

Some companies that are related to Inuvo include Trimantium Growthops (TGO), cbdMD (YCBD), I Synergy Group (IS3), Arena Events Group (ARE), NAHL Group (NAH), Ebiquity (EBQ), System1 Group (SYS1), Tech Mpire (TMP), Engage:BDR (EN1), Be Heard Group (BHRD), Grand Vision Media (GVMH), BlueRush (BTV), Matomy Media Group (MTMY), Jaywing (JWNG) and XTD (XTD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Inuvo investors own include NovaBay Pharmaceuticals (NBY), Ceragon Networks (CRNT), Opko Health (OPK), Biocept (BIOC), Nokia Oyj (NOK), BIOLASE (BIOL), CTI BioPharma (CTIC), Gevo (GEVO), Actinium Pharmaceuticals (ATNM) and Adamis Pharmaceuticals (ADMP).

Inuvo's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Perkins Capital Management Inc. (5.47%). View Institutional Ownership Trends for Inuvo.

INUV stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc.. View Insider Buying and Selling for Inuvo.

Shares of INUV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of INUV stock can currently be purchased for approximately $0.27.

Inuvo has a market capitalization of $13.23 million. Inuvo employs 60 workers across the globe.View Additional Information About Inuvo.

The official website for Inuvo is http://inuvo.com/.

Inuvo's mailing address is 500 President Clinton Ave Ste 300, LITTLE ROCK, AR 72201-1760, United States. The technology company can be reached via phone at +1-501-2058508.